Nishinomiya, Japan

Takashi Umezome


Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2003-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovating for Health: The Contributions of Takashi Umezome

Introduction

Takashi Umezome, an accomplished inventor based in Nishinomiya, Japan, has made significant strides in the field of pharmaceuticals. With two notable patents to his name, Umezome's work primarily focuses on compounds that have potential benefits for medical treatments, particularly in addressing obesity.

Latest Patents

Umezome's recent innovations include the development of an indole, indazole, and benzazole derivative. This compound, identified by the formula (I), exhibits β3-adrenoceptor-stimulating activity, making it promising as a medicament for the treatment of obesity. The structural complexity of this compound showcases Umezome's expertise and creativity in drug development.

Another significant patent under his name is an oxindole derivative, which is aimed at enhancing therapeutic approaches within the pharmaceutical industry. These innovations reflect his commitment to exploring new avenues for effective medical solutions.

Career Highlights

Throughout his career, Takashi Umezome has been affiliated with notable pharmaceutical companies, including Sumitomo Pharmaceuticals Company Limited and Dainippon Sumitomo Pharma Co., Ltd. His experience in these industries has undoubtedly contributed to his success in patent innovation and development.

Collaborations

Umezome has also collaborated with esteemed colleagues such as Teruhisa Tokunaga and W Ewan Hume. These partnerships highlight the importance of teamwork and shared knowledge in the pursuit of innovative solutions in healthcare.

Conclusion

Takashi Umezome's contributions to the field of pharmaceuticals through his patents illustrate the vital role inventors play in advancing medical technology. His work not only opens new possibilities for treatment but also inspires future research and innovation in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…